Cas:16809-88-4 Calcium bis(2-methylacrylate) manufacturer & supplier

We serve Chemical Name:Calcium bis(2-methylacrylate) CAS:16809-88-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Calcium bis(2-methylacrylate)

Chemical Name:Calcium bis(2-methylacrylate)
CAS.NO:16809-88-4
Synonyms:calcium,2-methylprop-2-enoate,hydrate;2-Propenoic acid, 2-methyl-, calcium salt (2:1);Methacrylic Acid Calcium Salt Hydrate;CalciuM Methacrylate Hydrate;Calcium bis(2-methylacrylate);EINECS 240-840-7
Molecular Formula:C8H10CaO4
Molecular Weight:210.241
HS Code:2916130090

Physical and Chemical Properties:
Melting point:>160ºC
Boiling point:160.5ºC at 760 mmHg
Density:N/A
Index of Refraction:
PSA:52.60000
Exact Mass:210.020493
LogP:1.14000

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like calcium,2-methylprop-2-enoate,hydrate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 240-840-7 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,CalciuM Methacrylate Hydrate Use and application,EINECS 240-840-7 technical grade,usp/ep/jp grade.


Related News: Health Canada said it was planning an onsite inspection this summer and that it would not accept any product or ingredients made at the plant until the inspection was complete. Calcium bis(2-methylacrylate) manufacturer Javier Valero-Elizondo, M.D., M.P.H., from the Houston Methodist DeBakey Heart and Vascular Center in Texas, and colleagues compared FT for individuals with ASCVD only, cancer only, both ASCVD and cancer, and neither ASCVD nor cancer using data from the National Health Interview Survey. Calcium bis(2-methylacrylate) supplier A key publication in a preclinical model demonstrated rigosertib��s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: ��A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.�� Cell 165, 643). Calcium bis(2-methylacrylate) vendor He said the FDA made its decision by fiat, and had not asked its advisors to consider whether the drug’s ability to remove a type of brain plaques known as beta amyloid would improve outcomes for patients. Calcium bis(2-methylacrylate) factory A key publication in a preclinical model demonstrated rigosertib��s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: ��A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.�� Cell 165, 643).